Logo image of ALB

ALBEMARLE CORP (ALB) Stock Fundamental Analysis

NYSE:ALB - New York Stock Exchange, Inc. - US0126531013 - Common Stock

94.05  -3.44 (-3.53%)

After market: 94.1895 +0.14 (+0.15%)

Fundamental Rating

3

ALB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. ALB has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ALB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ALB was profitable.
ALB had a positive operating cash flow in the past year.
Each year in the past 5 years ALB has been profitable.
ALB had a positive operating cash flow in each of the past 5 years.
ALB Yearly Net Income VS EBIT VS OCF VS FCFALB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B

1.2 Ratios

ALB has a Return On Assets of -11.27%. This is amonst the worse of the industry: ALB underperforms 84.34% of its industry peers.
With a Return On Equity value of -19.21%, ALB is not doing good in the industry: 80.72% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -11.27%
ROE -19.21%
ROIC N/A
ROA(3y)9.05%
ROA(5y)7.23%
ROE(3y)17.54%
ROE(5y)15%
ROIC(3y)N/A
ROIC(5y)N/A
ALB Yearly ROA, ROE, ROICALB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

ALB's Profit Margin has declined in the last couple of years.
ALB's Operating Margin has declined in the last couple of years.
ALB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y-35%
OM growth 5Y-26.28%
PM growth 3Y10.85%
PM growth 5Y-4.46%
GM growth 3YN/A
GM growth 5YN/A
ALB Yearly Profit, Operating, Gross MarginsALB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40

More info and screens

3

2. Health

2.1 Basic Checks

ALB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALB has more shares outstanding
ALB has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALB is higher compared to a year ago.
ALB Yearly Shares OutstandingALB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
ALB Yearly Total Debt VS Total AssetsALB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

ALB has an Altman-Z score of 1.71. This is a bad value and indicates that ALB is not financially healthy and even has some risk of bankruptcy.
ALB has a worse Altman-Z score (1.71) than 62.65% of its industry peers.
A Debt/Equity ratio of 0.35 indicates that ALB is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.35, ALB is in the better half of the industry, outperforming 67.47% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Altman-Z 1.71
ROIC/WACCN/A
WACC7.88%
ALB Yearly LT Debt VS Equity VS FCFALB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B

2.3 Liquidity

ALB has a Current Ratio of 2.44. This indicates that ALB is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.44, ALB is in the better half of the industry, outperforming 61.45% of the companies in the same industry.
A Quick Ratio of 1.58 indicates that ALB should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.58, ALB is doing good in the industry, outperforming 62.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 1.58
ALB Yearly Current Assets VS Current LiabilitesALB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for ALB have decreased strongly by -97.93% in the last year.
ALB shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.24% yearly.
ALB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -34.20%.
The Revenue has been growing by 23.30% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-97.93%
EPS 3Y75.42%
EPS 5Y32.24%
EPS Q2Q%-156.57%
Revenue 1Y (TTM)-34.2%
Revenue growth 3Y45.4%
Revenue growth 5Y23.3%
Sales Q2Q%-41.37%

3.2 Future

ALB is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.38% yearly.
Based on estimates for the next years, ALB will show a small growth in Revenue. The Revenue will grow by 2.39% on average per year.
EPS Next Y-108.29%
EPS Next 2Y-78.55%
EPS Next 3Y-42.4%
EPS Next 5Y-2.38%
Revenue Next Year-41.5%
Revenue Next 2Y-23.66%
Revenue Next 3Y-11.97%
Revenue Next 5Y2.39%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALB Yearly Revenue VS EstimatesALB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
ALB Yearly EPS VS EstimatesALB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 156.75, which means the current valuation is very expensive for ALB.
68.67% of the companies in the same industry are cheaper than ALB, based on the Price/Earnings ratio.
ALB is valuated expensively when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 91.95, the valuation of ALB can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALB indicates a slightly more expensive valuation: ALB is more expensive than 74.70% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.44, ALB is valued quite expensively.
Industry RankSector Rank
PE 156.75
Fwd PE 91.95
ALB Price Earnings VS Forward Price EarningsALB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALB Per share dataALB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

A cheap valuation may be justified as ALB's earnings are expected to decrease with -42.40% in the coming years.
PEG (NY)N/A
PEG (5Y)4.86
EPS Next 2Y-78.55%
EPS Next 3Y-42.4%

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.72%, ALB has a reasonable but not impressive dividend return.
ALB's Dividend Yield is comparable with the industry average which is at 3.26.
Compared to the average S&P500 Dividend Yield of 2.28, ALB is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.72%

5.2 History

The dividend of ALB has a limited annual growth rate of 3.69%.
ALB has been paying a dividend for at least 10 years, so it has a reliable track record.
ALB has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.69%
Div Incr Years30
Div Non Decr Years30
ALB Yearly Dividends per shareALB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5

5.3 Sustainability

ALB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-13.67%
EPS Next 2Y-78.55%
EPS Next 3Y-42.4%
ALB Yearly Income VS Free CF VS DividendALB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B

More info and screens

ALBEMARLE CORP

NYSE:ALB (1/21/2025, 6:40:00 PM)

After market: 94.1895 +0.14 (+0.15%)

94.05

-3.44 (-3.53%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)02-12 2025-02-12/amc
Inst Owners95.31%
Inst Owner Change-0.24%
Ins Owners0.22%
Ins Owner Change0.1%
Market Cap11.05B
Analysts69.03
Price Target114.73 (21.99%)
Short Float %11.28%
Short Ratio6.41
Dividend
Industry RankSector Rank
Dividend Yield 1.72%
Yearly Dividend1.6
Dividend Growth(5Y)3.69%
DP-13.67%
Div Incr Years30
Div Non Decr Years30
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-169.78%
Min EPS beat(2)-249.28%
Max EPS beat(2)-90.28%
EPS beat(4)1
Avg EPS beat(4)-65.31%
Min EPS beat(4)-249.28%
Max EPS beat(4)81.63%
EPS beat(8)4
Avg EPS beat(8)-22.65%
EPS beat(12)8
Avg EPS beat(12)-10.42%
EPS beat(16)12
Avg EPS beat(16)-2.63%
Revenue beat(2)1
Avg Revenue beat(2)1.81%
Min Revenue beat(2)-2.26%
Max Revenue beat(2)5.88%
Revenue beat(4)3
Avg Revenue beat(4)3.35%
Min Revenue beat(4)-2.26%
Max Revenue beat(4)6.99%
Revenue beat(8)3
Avg Revenue beat(8)-0.88%
Revenue beat(12)4
Avg Revenue beat(12)-0.81%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)0.9%
PT rev (3m)4.04%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-165.79%
EPS NY rev (1m)0%
EPS NY rev (3m)-671%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-20.68%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-1.81%
Valuation
Industry RankSector Rank
PE 156.75
Fwd PE 91.95
P/S 1.7
P/FCF N/A
P/OCF 18.33
P/B 1.08
P/tB 1.32
EV/EBITDA N/A
EPS(TTM)0.6
EY0.64%
EPS(NY)1.02
Fwd EY1.09%
FCF(TTM)-12
FCFYN/A
OCF(TTM)5.13
OCFY5.46%
SpS55.32
BVpS87.12
TBVpS71.1
PEG (NY)N/A
PEG (5Y)4.86
Profitability
Industry RankSector Rank
ROA -11.27%
ROE -19.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)9.05%
ROA(5y)7.23%
ROE(3y)17.54%
ROE(5y)15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.57%
ROCE(5y)8.65%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-35%
OM growth 5Y-26.28%
PM growth 3Y10.85%
PM growth 5Y-4.46%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 353.56%
Cap/Sales 30.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.44
Quick Ratio 1.58
Altman-Z 1.71
F-Score3
WACC7.88%
ROIC/WACCN/A
Cap/Depr(3y)431.6%
Cap/Depr(5y)412.07%
Cap/Sales(3y)22.75%
Cap/Sales(5y)23.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-97.93%
EPS 3Y75.42%
EPS 5Y32.24%
EPS Q2Q%-156.57%
EPS Next Y-108.29%
EPS Next 2Y-78.55%
EPS Next 3Y-42.4%
EPS Next 5Y-2.38%
Revenue 1Y (TTM)-34.2%
Revenue growth 3Y45.4%
Revenue growth 5Y23.3%
Sales Q2Q%-41.37%
Revenue Next Year-41.5%
Revenue Next 2Y-23.66%
Revenue Next 3Y-11.97%
Revenue Next 5Y2.39%
EBIT growth 1Y-165.41%
EBIT growth 3Y-5.49%
EBIT growth 5Y-9.1%
EBIT Next Year-47.73%
EBIT Next 3Y-4.36%
EBIT Next 5Y16.12%
FCF growth 1Y-358.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25.46%
OCF growth 3Y18.38%
OCF growth 5Y19.4%